SCHEMBL24677465

SCHEMBL24677465

c1ccc(-c2ccc(-c3ccccc3)c(-c3ccc(-n4c5ccccc5c5cc(-n6c7ccccc7c7ccccc76)ccc54)cc3)c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.49
ATM Q13315 2/20 0.49
KDM4E B2RXH2 1/20 0.49
HDAC4 P56524 1/20 0.40
TSPO P30536 1/20 0.38
RAC2 P15153 1/20 0.36
RAC3 P60763 1/20 0.36
CDC42 P60953 1/20 0.36
RAC1 P63000 1/20 0.36
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
MAPT P10636 2/20 0.36
HTT P42858 2/20 0.36
EDNRA P25101 2/20 0.36
EDNRB P24530 1/20 0.36
APAF1 O14727 1/20 0.36
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.36
THRB P10828 1/20 0.36
XBP1 P17861 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24677343 1.00 L3MBTL1 (0.49) L3MBTL1ATMKDM4EHDAC4TSPO
SCHEMBL24677342 1.00 L3MBTL1 (0.49) L3MBTL1ATMKDM4EHDAC4TSPO
SCHEMBL26740991 0.96 L3MBTL1 (0.51) L3MBTL1ATMKDM4EHDAC4TSPO
SCHEMBL24677361 0.94 L3MBTL1 (0.44) L3MBTL1ATMKDM4EHDAC4TSPO
SCHEMBL22876595 0.94 L3MBTL1 (0.49) L3MBTL1ATMKDM4EHDAC4TSPO
SCHEMBL19762211 0.94 L3MBTL1 (0.49) L3MBTL1ATMKDM4EHDAC4TSPO
SCHEMBL15502634 0.94 L3MBTL1 (0.49) L3MBTL1ATMKDM4EHDAC4TSPO
SCHEMBL20865201 0.94 L3MBTL1 (0.55) L3MBTL1ATMKDM4EHDAC4TSPO
SCHEMBL20865044 0.94 L3MBTL1 (0.55) L3MBTL1ATMKDM4EHDAC4TSPO
SCHEMBL14429628 0.94 L3MBTL1 (0.55) L3MBTL1ATMKDM4EHDAC4TSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159550-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-05-25 US disclosed
US-20230159550-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-05-25 US disclosed
US-11485706-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2022-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11485706-B2 Organic electroluminescent materials and devices SOD1, L1CAM, EPCAM L3MBTL1 1135/4885ATM 1277/4885KDM4E 3594/4885
US-20230159550-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, ODC1 L3MBTL1 888/4885ATM 3709/4885KDM4E 2090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.